Home
    • Plans Blog Contact
    Neuroone Medical Technologies Corp logo

    Neuroone Medical Technologies Corp

    NMTC
    Last price US$1.96
    Market cap US$24.4m
    12M price change -63.74%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Abbott LaboratoriesABT Industry peer DexCom IncDXCM Industry peer Edwards Lifesciences CorpEW Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Neuroone Medical Technologies Corp Overview

    Industry: Medical Devices

    Sector: Healthcare

    NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota. NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, br Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Neuroone Medical Technologies Corp into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed May 12, 2026

    Quarterly result summary

    Revenue was $2.4M (+72% YoY). Net loss was -$2.1M (-8% YoY). Cash was $2.8M.

    Revenue $2.4M +72% YoY
    Net loss -$2.1M -8% YoY
    Cash $2.8M reported

    What changed

    • Revenue +72% YoY to $2.4M.
    • Net loss -8% YoY to -$2.1M.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing AMENDMENT NO. 1 TO FORM 10-Q Jun 12, 2026 SEC filing QUARTERLY REPORT May 12, 2026 SEC filing CURRENT REPORT May 12, 2026 Earnings release PRESS RELEASE, DATED FEBRUARY 17, 2026 Feb 17, 2026 SEC filing CURRENT REPORT Feb 17, 2026 SEC filing QUARTERLY REPORT Feb 17, 2026 SEC filing AMENDMENT NO. 1 TO FORM 10-K Jan 23, 2026 SEC filing ANNUAL REPORT Dec 17, 2025 SEC filing CURRENT REPORT Dec 17, 2025 Earnings release PRESS RELEASE, DATED DECEMBER 17, 2025 Dec 17, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 3.00/5
    Neuroone Medical Technologies Corp boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Medical Devices industry , Abbott Laboratories , DexCom Inc , Edwards Lifesciences Corp are companies with high ratings.

    Return on Equity

    Score 0.17/5
    Neuroone Medical Technologies Corp exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Neuroone Med... NMTC US$24.4m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 0.42/5
    Neuroone Medical Technologies Corp olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    Neuroone Med... NMTC US$24.4m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Medical Devices industry , Abbott Laboratories , DexCom Inc , Edwards Lifesciences Corp are companies with high ratings.

    Leverage

    Score 2.98/5
    Neuroone Medical Technologies Corp attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
    Neuroone Med... NMTC US$24.4m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Neuroone Medical Technologies Corp logo

    Neuroone Medical Technologies Corp

    US$1.96

    US$24.4m

    -16.24%

    -63.74%